Tue Oct 07 08:30:00 UTC 2025: **Summary:**

The U.S. is facing a critical shortage of over 100 essential drugs, ranging from vitamins to cancer treatments and vaccines. This shortage impacts hospitals, pharmacies, and patients nationwide, including in the Inland Northwest. The situation is attributed to various factors, including supply chain disruptions, manufacturing issues, new regulations, and a lack of incentive for drug companies to produce low-profit generic drugs. The shortages lead to treatment delays, the use of less effective alternatives, and increased stress for both healthcare providers and patients. While President Obama issued an executive order to address the issue, many are skeptical it will be sufficient to resolve the complex problem.

**News Article:**

**Nationwide Drug Shortage Leaves Patients Vulnerable, Doctors Scrambling**

**Spokane, WA** – A concerning shortage of over 100 crucial medications, from routine vitamins to life-saving cancer treatments and vaccines, is sweeping the nation, leaving healthcare providers and patients in a precarious position. The American Society of Health-System Pharmacists reports widespread scarcity, impacting hospitals, pharmacies, and individuals across the country, including the Inland Northwest.

“It’s almost like we are no longer a first-world country,” said Spokane oncologist Arvind Chaudhry. “We are practicing third-world medicine in a first-world country.”

Locally, pharmacists report shortages of methotrexate (used for rheumatoid arthritis), vitamin K (essential for surgical procedures), and cytarabine (a cancer-fighting drug). The crisis is forcing doctors to delay treatments, choose less effective alternatives, and, in some tragic cases, witness patients dying while waiting for medication.

“Sometime we have to put off chemotherapy. Sometimes we have to choose alternatives that may not be as effective,” says Chaudhry, adding that he is short on leucovorin, cytarabine, and other drugs used to fight cancer. “There may be times where there is no alternative. … It’s impacting our day-to-day decisions about taking care of our patients. And it’s extremely stressful for a physician and the patient.”

The shortage is attributed to a complex web of factors, including disruptions to the supply chain from natural disasters, manufacturing problems in factories, stricter FDA regulations, and, critically, a perceived lack of profitability for drug companies to produce generic medications.

“When they lose their patents [and become generic], it’s like a downward spiral about how the government pays for the drugs, so the manufacturers and the drug companies have no incentive to make these drugs,” Chaudhry says.

While President Obama issued an executive order last October aimed at easing the shortages, some remain skeptical of its effectiveness in addressing the deep-seated issues. Michael Brandt, a pharmacy clinical supervisor at Kootenai Medical Center, acknowledged the complexities, stating, “This is a multifactor problem that reaches … every aspect of society. And to fix it is somewhat of an enigma.”

The situation is particularly challenging for smaller, rural pharmacies, as they lack the financial resources to stockpile medications during periods of disruption. Pharmacists also report difficulties obtaining generics, forcing them to resort to more expensive brand-name alternatives when available. The long-term impact of these shortages on patient health and the healthcare system remains a major concern.

Read More